Less Ads, More Data, More Tools Register for FREE

Pin to quick picksC&C Group Regulatory News (CCR)

Share Price Information for C&C Group (CCR)

Share Price is delayed by 15 minutes
Get Live Data
94.50    2.30 (2.49%)
Bid:
94.10
Ask:
94.40
Spread: 0.30 (0.319%)
Market Cap: £348.08m
CCR Live PriceLast checked at - London Stock Exchange

Intraday C&C Group Share Chart

AGM Statement

13 Jul 2023 07:00

C&C Group plc (‘C&C’ or the 'Group’) issues the following update for the period 1 March 2023 to 30 June 2023 ahead of its Annual General Meeting (AGM) which will be held at 11am today.

Our branded business has had an encouraging performance in early FY2024, building on growth achieved in FY2023, with Net Sales Revenue of our branded business up 10%(i) in the four months to the end of June. Net Sales Revenue of our core brands, principally Tennent’s and Bulmers were up 9%(i) in the same period, with each brand continuing to grow category share(ii).

We are pleased to report progress in resolving the Enterprise Resource Planning (‘ERP’) system implementation issues in the Group’s GB distribution business outlined in the FY2023 Preliminary Results Announcement in May 2023, with service levels steadily improving. While this progress is consistent with our immediate objectives, we continue to target further improvements to On Time in Full (‘OTIF’) metrics consistent with our aim to deliver outstanding service to our customers. The ERP system implementation is a key step in the digital transformation and optimisation of the business, which will enable the consolidation and standardisation of processes across the Group, drive efficiencies, improve automation, improve customer experience, and provide a platform for digital commerce.

C&C’s strong balance sheet and free cash flow generation capabilities are reflected in the reinstatement of a dividend of 3.79 cents per share for FY2023, subject to shareholder approval at today’s AGM. FY2023 leverage(iii) was 1.3x at 28 February 2023. As previously communicated, while leverage will temporarily increase as a result of the ERP system implementation issues, it is expected to be within the Group’s leverage target range of 1.5x to 2x for the end of the financial year in February 2024. The potential for returns of capital will be kept under review having regard to a range of factors including wider economic indicators, market conditions and progress in restoring margins.

Non-Executive Director Appointment & CFO Recruitment Process

C&C is pleased to announce the appointment of Angela Bromfield as an independent Non-Executive Director, effective from the conclusion of today’s 2023 AGM. On joining the Board, Angela will succeed Helen Pitcher as Chair of the Remuneration Committee.

Angela’s appointment follows a thorough search process led by the Nomination Committee, in conjunction with an independent executive search firm. Angela brings wide business strategy, communications and marketing experience to the Board, together with significant experience as an independent Director and as Remuneration Committee Chair at several UK listed companies.

Angela is currently Senior Independent Director, Chair of the Remuneration and ESG Committees and a member of the Nominations Committee of Harworth Group plc. She is also a Non-Executive Director, Chair of the Remuneration Committee and a member of the Audit and Nominations Committees of Marshalls plc. Angela has previously been a Non-Executive Director and Chair of the Remuneration Committee at Churchill China plc and Zotefoams plc.

Separately, the Group’s process to recruit a new Group Chief Financial Officer continues and an update will be provided in due course.

Patrick McMahon, Group Chief Executive Officer, commented: “We are pleased with the start our branded business has made in FY2024. We are also reporting progress on the resolution of the ERP system implementation issues. However, the Group’s performance is not at the level we planned, because of the ERP issues, and resolving them fully including the permanent restoration of OTIF metrics, remains our immediate objective and focus”.

Ralph Findlay, Executive Chair, commented: “Despite the challenges relating to the ERP system implementation, the performance of our brands, the strength of the Group’s balance sheet and our robust cash generating capability have enabled us to recommend a dividend to our shareholders.

Separately, I am delighted to welcome Angela Bromfield to the Board of C&C as a Non-Executive Director and Chair of the Remuneration Committee. I look forward to working with her in the years ahead. I also thank Helen Pitcher and Jim Thompson who step down from the Board today for their support and contributions to the Group.”

This announcement is made in accordance with Listing Rule 9.6.11 and there is no further information to be disclosed pursuant to Listing Rule 9.6.13.

(i)

 

Unaudited financials.

(ii)

 

Bulmers: Ireland (NIQ) Off-Trade: Data is 12 weeks to 23.04.23. Ireland and NI (CGA) On-Trade Data is 12 weeks to end of April 2023.

 

Tennent’s and Magners Original: Data is 12 weeks to 20.05.23 for On-Trade and 14.05.23 for Off-Trade.

(iii)

 

Leverage is defined as net debt to earnings before exceptional items, finance income, finance expense, tax, depreciation, amortisation and share of equity accounted investments profit after tax. Net debt comprises borrowings (net of issue costs), lease liabilities capitalised less cash.

ENDS

Contacts C&C Group plc Riona Heffernan, Group Finance & Investor Relations Director Email: riona.heffernan@candcgroup.com

UK & International Media Richard Hayhoe Email: richard.hayhoe@candcgroup.com

Investors, Analysts & Irish Media FTI Consulting Jonathan Neilan / Paddy Berkery / Aline Oliveira Tel: +353 86 231 4135 / +353 86 602 5988 / +353 83 833 1644 Email: CandCGroup@fticonsulting.com

About C&C Group plc

C&C Group plc is a leading, vertically integrated premium drinks company which manufactures, markets and distributes branded beer, cider, wine, spirits, and soft drinks across the UK and Ireland.

C&C Group’s portfolio of owned/exclusive brands include: Bulmers, the leading Irish cider brand; Tennent’s, the leading Scottish beer brand; Magners the premium international cider brand; as well as a range of fast-growing, premium and craft ciders and beers, such as Heverlee, Menabrea, Five Lamps and Orchard Pig. C&C exports its Magners and Tennent’s brands to over 40 countries worldwide. C&C Group has owned brand and contract manufacturing/packing operations in Co.Tipperary, Ireland and Glasgow, Scotland. C&C is the No.1 drinks distributor to the UK and Ireland hospitality sectors. Operating through the Matthew Clark, Bibendum, Tennent’s and Bulmers Ireland brands, the Group has a market leading range, scale and reach including an intimate understanding of the markets it serves. Together this provides a key route-to-market for major international beverage companies.

C&C Group is a FTSE 250 company headquartered in Dublin and is listed on the London Stock Exchange.

Note regarding forward-looking statements

This announcement includes forward-looking statements, including statements concerning current expectations about future financial performance and economic and market conditions which C&C believes are reasonable. However, these statements are neither promises nor guarantees, but are subject to risks and uncertainties, including those factors discussed in our FY2023 Annual Report that could cause actual results to differ materially from those anticipated.

View source version on businesswire.com: https://www.businesswire.com/news/home/20230712278534/en/

Copyright Business Wire 2023

Date   Source Headline
3rd Jun 20263:59 pmRNSHolding(s) in Company
2nd Jun 20265:19 pmRNSHolding(s) in Company
2nd Jun 202612:04 pmRNSHolding(s) in Company
1st Jun 20266:18 pmRNSTotal Voting Rights
28th May 20264:30 pmRNSHolding(s) in Company
28th May 202610:40 amRNSDirector/PDMR Shareholding
27th May 20264:43 pmRNSHolding(s) in Company
19th May 20263:54 pmRNSDirector/PDMR Shareholding
19th May 20267:00 amRNSFinal Results
8th May 20267:00 amRNSHolding(s) in Company
7th May 20265:28 pmRNSHolding(s) in Company
1st May 20264:28 pmRNSHolding(s) in Company
1st May 20264:25 pmRNSTotal Voting Rights
30th Apr 20264:49 pmRNSHolding(s) in Company
29th Apr 202611:14 amRNSHolding(s) in Company
29th Apr 202611:05 amRNSHolding(s) in Company
16th Apr 20264:37 pmRNSDirector/PDMR Shareholding
9th Apr 202612:12 pmRNSChief Financial Officer Update
1st Apr 202611:58 amRNSTotal Voting Rights
20th Mar 20265:42 pmRNSBoard Committee Membership Update
17th Mar 20263:30 pmRNSDirector/PDMR Shareholding
13th Mar 202612:33 pmRNSHolding(s) in Company
6th Mar 20261:15 pmRNSAcquisition of Innis & Gunn Brand
2nd Mar 202611:31 amRNSTotal Voting Rights
24th Feb 20261:09 pmRNSDirectorate change
18th Feb 202611:56 amRNSDirector/PDMR Shareholding
6th Feb 202612:34 pmRNSDirector/PDMR Shareholding
5th Feb 20267:02 amRNSAppointment of Chief Financial Officer
2nd Feb 202612:55 pmRNSTotal Voting Rights
23rd Jan 20267:00 amRNSFY26 Trading Update
19th Jan 20265:26 pmRNSDirector/PDMR Shareholding
9th Jan 20263:21 pmRNS2025 AGM Voting Update Statement
5th Jan 202611:40 amRNSTotal Voting Rights
23rd Dec 20255:53 pmRNSDirector/PDMR Shareholding
23rd Dec 20255:53 pmRNSDirector/PDMR Shareholding
22nd Dec 20251:12 pmRNSHolding(s) in Company
22nd Dec 20251:12 pmRNSHolding(s) in Company
17th Dec 202512:36 pmRNSDirector/PDMR Shareholding
17th Dec 202512:36 pmRNSDirector/PDMR Shareholding
10th Dec 20256:08 pmRNSHolding(s) in Company
1st Dec 20253:27 pmRNSTotal Voting Rights
26th Nov 202511:40 amRNSHolding(s) in Company
24th Nov 20254:38 pmRNSHolding(s) in Company
19th Nov 20254:46 pmRNSDirector/PDMR Shareholding
19th Nov 202510:45 amRNSDirector/PDMR Shareholding
18th Nov 20253:30 pmRNSDirector/PDMR Shareholding
14th Nov 202511:19 amRNSHolding(s) in Company
13th Nov 20251:45 pmRNSHolding(s) in Company
3rd Nov 20253:09 pmRNSTotal Voting Rights
28th Oct 20257:00 amRNSInterim Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.